Have a personal or library account? Click to login
Clinical and Laboratory Characteristics of Children with Idiopathic Thrombocytopenic Purpura Cover

Clinical and Laboratory Characteristics of Children with Idiopathic Thrombocytopenic Purpura

Open Access
|Feb 2026

References

  1. Zheng SS, Perdomo JS, Ahmadi Z, Chong BH. Indirect detection of anti-platelet antibodies in immune thrombocytopenia. Pathology. 2021; 53(6): 759–62.
  2. Schmidt DE, Heitink-Polle KMJ, Porcelijn L, et al. Antiplatelet antibodies in childhood immune thrombocytopenia: Prevalence and prognostic implications. J Thromb Haemost. 2020; 18(5): 1210–20.
  3. Remiker A, Neunert C. Splenectomy for immune thrombocytopenia: the evolution and preservation of treatment. Haematologica. 2020; 105(11): 2507–9.
  4. Neunert C, Terrell RD, Arnold MD, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019; 3(23): 3829–66.
  5. Gözmen S, Karapnar TH, Tüfekçi Ö, et al. B-cell-activating factor, a proliferation inducing ligand and co-stimulatory molecules in the pathogenesis of immune thrombocytopenia in childhood. Blood Coagul Fibrinolysis. 2016; 27(5): 494–9.
  6. Vrbensky JR, Arnold DM, Kelton JG, et al. Increased cytotoxic potential of CD8+ T cells in immune thrombocytopenia. Br J Haematol. 2020; 188(5): e72–e76.
  7. Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017; 6(2): 16.
  8. Kühne T. Diagnosis and management of immune thrombocytopenia in childhood. Hamostaseologie. 2017; 37(1): 36–44.
  9. Morin E, Sadarangani M. Recurrent immune thrombocytopenia following different vaccines. BMJ Case Rep. 2019;12(9):e231260.
  10. Singh G, Bansal D, Wright NAM. Immune Thrombocytopenia in Children: Consensus and Controversies. Indian J Pediatr. 2020; 87(2): 150–57.
  11. Kohli R, Chaturvedi S. Epidemiology and Clinical Manifestations of Immune Thrombocytopenia. Hamostaseologie. 2019; 39(3): 238–49.
  12. Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019; 3(22): 3780–3817.
  13. Güngör T, Arman Bilir Ö, Koşan Çulha V, et al. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity. Pediatr Neonatol. 2019; 60(4): 411–16.
  14. Bennett CM, Neunert C, Grace RF, et al. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants. Pediatr Blood Cancer. 2018; 65(10). e26736
  15. Despotovic JM, Grimes AB. Pediatric ITP: is it different from adult ITP? Hematology Am Soc Hematol Educ Program. 2018; 2018(1): 405–11.
  16. Schifferli A, Holbro A, Chitlur M, et al. Intercontinental Cooperative ITP Study Group (ICIS). A comparative prospective observational study of children and adults with immune thrombocytopenia: 2-year follow-up. Am J Hematol. 2018; 93(6): 751–59.
  17. Buchanan RG, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr. 2002; 141(5): 683–8.
  18. Rodeghiero F, Michel M, Gernsheimer T, et al. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood. 2013; 121(14): 2596–606.
  19. Weycker D, Hanau A, Hatfield M, et al. Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis. J Med Econ. 2020; 23(2): 184–92.
  20. Schmidt D, Lakerveld A, Heitink-Pollé K, et al. Antiplatelet antibody immunoassays in childhood immune thrombocytopenia: a systematic review. Vox Sang. 2020; 115(4): 323–33.
  21. Zheng SS, Perdomo JS, Ahmadi Z, Chong BH. Indirect detection of anti-platelet antibodies in immune thrombocytopenia. Pathology. 2021; 53(6): 759–62.
  22. Schmidt DE, Heitink-Polle KMJ, Porcelijn L, et al. Antiplatelet antibodies in childhood immune thrombocytopenia: Prevalence and prognostic implications. J Thromb Haemost. 2020; 18(5): 1210–20.
  23. Kamioka PE, Liphaus BL, Beatrice JM, et all. Latent and Overt Polyautoimmunity in Children and Adolescents With Immune Thrombocytopenia. J Pediatr Hematol Oncol. 2020; 42(7): e606–e609.
  24. Lee A, Hong J, Chung H, et al. Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia. Sci Rep. 2020; 10(1): 9370.
  25. Lassandro G, Carriero F, Palmieri, et al. Serum Vitamin D Levels in Children with Immune Thrombocytopenia. Endocr Metab Immune Disord Drug T A p r ets. 2020; 20(2): 221–6.
  26. Shaheen IA, Aboukhalil R, Abulata N, Abdel-Raouf R, Meligy B, Abdel-Dayem O. Vitamin D Insufficiency is Not Associated With Pediatric and Adolescent Immune Thrombocytopenia: A Study in Conjunction With its Receptor Genetic Polymorphisms. J Pediatr Hematol Oncol. 2021; 43(1): e1–e6.
  27. Vianelli N, Galli M, de Vivo A, et al. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica. 2005; 90(1): 72–7.
  28. Pizzi M, Friziero A, Vianello F, et al. Histology of the spleen in immune thrombocytopenia: clinical-pathological characterization and prognostic implications. Eur J Haematol. 2021; 106(2): 281–9.
  29. Woo JH, Park SH, Park YK, et al. Postsplenectomy recurrence of thrombocytopenia with an accessory spleen. Korean J Intern Med. 2004; 19(3): 199–201.
  30. Miao W, Song B, Shi B, et al. Immune Thrombocytopenia Plasma-Derived Exosomes Impaired Megakaryocyte and Platelet Production through an Apoptosis Pathway. Thromb Haemost. 2021; 121(4): 495–505.
  31. Lee YK, Yoon HS, Lee EH, Cho SY. Can we Predict the Clinical Course of Immune Thrombocytopenia in Children by The Mean Platelet Volume? A Preliminary Study. Clin Lab. 2021; 67(3). doi: 10.7754/Clin.Lab.2020.200715.
  32. Adly AA, Ragab IA, Ismail EA, Farahat MM. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia. Platelets. 2015; 26(7): 645–50.
  33. Parodi E, Russo G, Farruggia P, et al. Management strategies for newly diagnosed immune thrombocytopenia in Italian AIEOP Centres: do we overtreat? Data from a multicentre, prospective cohort study. Blood Transfus. 2020; 18(5): 396–405.
  34. Palandri F, Polverelli N, Catani L, et al. The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre longterm study. Am J Hematol. 2014; 89(11): 1047–50.
  35. Navez J, Hubert C, Gigot JF, et al. Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura? Platelets. 2015; 26(6): 573–6.
DOI: https://doi.org/10.2478/eabr-2024-0016 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 379 - 389
Submitted on: Sep 8, 2024
|
Accepted on: Oct 9, 2024
|
Published on: Feb 25, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Marija Medovic, Bojana Markovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.